617 related articles for article (PubMed ID: 19018745)
1. [Vaccination scheme in advanced chronic kidney disease].
Barril G; Teruel JL
Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal transplantation.
García-Agudo R; Aoufi Rabih S; Araque Torres P; Dolores Fraga Fuentes M; Carlos Valenzuela Gámez J; Mancha Ramos J; María Tenías Burillo J
Transplant Proc; 2012 Nov; 44(9):2532-4. PubMed ID: 23146445
[TBL] [Abstract][Full Text] [Related]
5. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
6. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
8. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
McNulty CA; Bowen JK; Williams AJ
Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
[TBL] [Abstract][Full Text] [Related]
10. [Editorial of the "vaccination issue" of KMIL--what have demonstrated Prevenar and Fendrix vaccines].
Beran J
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):87-90. PubMed ID: 17051468
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders.
Brown CM; Donlon S; O'Kelly P; Casey AM; Collier C; Conlon PJ; Walshe JJ
Ren Fail; 2011; 33(3):276-9. PubMed ID: 21401350
[TBL] [Abstract][Full Text] [Related]
14. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
Urbanowicz W
Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
[TBL] [Abstract][Full Text] [Related]
16. Immunization status of thirty patients with sickle cell disease five years post hepatitis B vaccination. A comparison with normal controls.
Jones-Lecointe A; Swanston WM; Charles WP; Simeon D
West Indian Med J; 2001 Dec; 50(4):317-8. PubMed ID: 11993025
[TBL] [Abstract][Full Text] [Related]
17. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
18. [Persistence of anti-HB antibodies after vaccination against hepatitis B in medical staff of the Memorial Child Health Institute in 1994-1998].
Migdał A; Nowak-Parzygnat B; Madaliński K
Med Pr; 2003; 54(5):445-52. PubMed ID: 14978893
[TBL] [Abstract][Full Text] [Related]
19. The significance of immunocompromised condition in the prophylaxis of hepatitis B in chronic renal insufficiency.
Gasparović V; Puljević D; Gjurasin M; Delimar N; Borcić D; Gasparović H; Mihaljević I
Acta Med Croatica; 1993; 47(2):61-5. PubMed ID: 7505130
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]